TCI Wealth Advisors Inc. Sells 180 Shares of Danaher Corporation $DHR

TCI Wealth Advisors Inc. lowered its position in shares of Danaher Corporation (NYSE:DHR) by 7.2% in the 2nd quarter, HoldingsChannel reports. The firm owned 2,335 shares of the conglomerate’s stock after selling 180 shares during the quarter. TCI Wealth Advisors Inc.’s holdings in Danaher were worth $461,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of DHR. GHP Investment Advisors Inc. lifted its stake in shares of Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock valued at $25,000 after acquiring an additional 99 shares during the last quarter. Sierra Ocean LLC lifted its stake in shares of Danaher by 116.9% in the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock valued at $29,000 after acquiring an additional 76 shares during the last quarter. Smallwood Wealth Investment Management LLC bought a new stake in shares of Danaher in the 1st quarter valued at about $31,000. Dunhill Financial LLC lifted its stake in shares of Danaher by 68.4% in the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock valued at $34,000 after acquiring an additional 67 shares during the last quarter. Finally, Ameriflex Group Inc. bought a new stake in shares of Danaher in the 4th quarter valued at about $38,000. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Down 2.3%

DHR stock opened at $181.56 on Friday. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $279.90. The business’s 50 day moving average price is $199.54 and its two-hundred day moving average price is $197.72. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. The company has a market capitalization of $130.01 billion, a price-to-earnings ratio of 38.63, a price-to-earnings-growth ratio of 2.65 and a beta of 0.75.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping analysts’ consensus estimates of $1.64 by $0.16. The firm had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The business’s revenue for the quarter was up 3.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be paid a $0.32 dividend. The ex-dividend date is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.7%. Danaher’s dividend payout ratio is presently 27.23%.

Analysts Set New Price Targets

A number of research firms have recently weighed in on DHR. Deutsche Bank Aktiengesellschaft lowered their target price on Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. Wells Fargo & Company reduced their price target on Danaher from $210.00 to $205.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 23rd. Bank of America reduced their price target on Danaher from $230.00 to $220.00 and set a “buy” rating on the stock in a report on Monday. Barclays restated an “overweight” rating and set a $225.00 price target (up previously from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Finally, Royal Bank Of Canada set a $241.00 price target on Danaher in a report on Tuesday, September 2nd. Seventeen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and a consensus price target of $245.91.

Insider Buying and Selling at Danaher

In related news, Director Teri List sold 2,778 shares of the company’s stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director owned 20,751 shares in the company, valued at $4,379,706.06. This represents a 11.81% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 11.10% of the stock is owned by insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.